President and CEO, Co-Founder
Fight Like Mason Foundation

Chantelle is a licensed hairstylist by trade and a recent graduate of the Firefighter Program at St.Clair College. Along with running Fight Like Mason Foundation she is also pursuing her dream, as well as fulfilling Mason's dream, of being an active Firefighter to further help her community.

Chantelle Bacon & Iain Macri are chief operators and co-founders of Fight Like Mason Foundation. The grassroots organization was formed in 2016 after their son Mason passed away at 4 years old from Rhabdomyosarcoma.

Before passing, Chantelle & Iain made Mason a promise... a promise that they would continue his fight for all the other children diagnosed with childhood cancer. From their experiences, Chantelle and Iain have aimed to fill the gaps in pediatric oncology, helping children and families at every step of their medical journey --- from diagnosis, into remission, survivorship and even bereavement.

With over 10 unique programs, including: research grants, custom medical equipment and comfort and empowering support programs, the organization has raised 1.6 million for their cause in 6 years as a charity.

Chantelle & Iain have been able to continue Mason's fight and legacy by committing to their Mission ; Improving the treatment, care and quality of life of patients diagnosed with childhood cancer.

Fight Like Mason Foundation is here to "Defeat the villain for good!"

MD, MPH 
Assistant Professor of Pediatrics, Harvard Medical School 
Attending Physician Pediatric Oncology, Dana-Farber/Boston Children's Cancer and Blood Disorders Center 

Dr. Kira Bona received her Doctor of Medicine from the Yale University School of Medicine and her MPH from the Harvard T.H. Chan School of Public Health. She completed her pediatrics residency at Boston Children’s Hospital and Boston Medical Center and her pediatric hematology/oncology fellowship at Dana-Farber/Boston Children’s Hospital. 
 
Dr. Bona is an NIH and foundation-funded physician-scientist with a research lab focused on poverty-associated disparities in childhood cancer outcomes. She has formal training in health services research and clinical expertise in pediatric hematologic malignancies. Her research program aims to improve outcomes in pediatric cancer by systematically considering social determinants of health as risk factors for poor outcome and integrating them into the existing robust clinical trial and basic science models of discovery and care in pediatric cancer.  
  
Her current research funded includes (1) the first trial-embedded investigations of poverty and outcome; (2) the first trial-embedded health equity intervention; and (3) collaborative translational investigation of poverty-associated treatment resistance.  
 
Dr. Bona has been the recipient of several awards and honors including young investigator awards from the American Society of Clinical Oncology and St. Baldrick’s Foundation and annual teaching awards from the Boston Combined Residency Program since 2018.

Nick Fischer is a Research Associate in David Malkin’s lab at The Hospital for Sick Children. He completed his PhD in the Department of Medical Biophysics at UofT where he studied the structural and functional consequences of TP53 mutations. In the Malkin lab, Nick is studying mutant p53 biology in the context of Li-Fraumeni Syndrome and tumor-immune surveillance.

MD, FRCPC
Pediatric Oncologist, McMaster Children's Hospital
Associate Medical Director, POGO
Associate Professor, McMaster University

Dr. Paul Gibson is a pediatric oncologist who earned his medical degree from Queen’s University. He completed his pediatric residency training at B.C. Children’s Hospital, followed by subspecialty training at The Hospital for Sick Children. In 2010, he joined the Section of Pediatric Hematology and Oncology at Children's Hospital, London Health Sciences Centre full time, before moving to the Division of Pediatric Hematology and Oncology at McMaster Children’s Hospital in 2019.

Dr. Gibson holds the position of Associate Professor at McMaster University and is also the Associate Chief Medical Information Officer at Hamilton Health Sciences. He has been the Associate Medical Director of the Pediatric Oncology Group of Ontario (POGO) since 2015. In this role, he provides medical support to the eight POGO Satellite Clinic programs across the province and leads POGO’s efforts in drug and technology access.

Dr. Gibson is the Chair of the Management Committee of the Cancer in Young People in Canada (CYP-C), which is Canada’s national, population-based childhood cancer registry. His research interests include medical informatics and supportive care in pediatric cancer.

OC, MB, ChB, FRCPC, FAAP
Co-Founder, Pediatric Oncology Group of Ontario (POGO)
Emeritus Professor of Pediatrics and Surgery at the University of Toronto
Past Senior Staff Oncologist and Director After-Care Program, Division of Haematology/Oncology, The Hospital for Sick Children

Dr. Mark Greenberg is a co-founder of Pediatric Oncology Group of Ontario (POGO). From 2022-2012, he was POGO's Medical Director and POGO Chair in Childhood Cancer Control at the University of Toronto. He is also Emeritus Professor of Pediatrics and Surgery at the University of Toronto and past Senior Staff Oncologist and Director AfterCare Program in the Division of Haematology/Oncology at the Hospital for Sick Children. 

From 1991-1998 he was Chief of Oncology at The Hospital for Sick Children. From 1998-2008 he co-chaired the national Canadian Childhood Cancer Surveillance and Control Program. He is a previous North American President of the International Society of Pediatric Oncology. He was a founding member of the Childhood Cancer Survivor Study (CCSS), a major multiyear cohort study funded by the US NIH. He is the author and co-author of over 200 papers and many book chapters.

Dr. Greenberg was inducted as an Officer of the Order of Canada in 2001 in recognition of his outstanding contributions to the field of childhood cancer. In 2007, he was awarded the prestigious O. Harold Warwick prize, a National Cancer Institute of Canada Award of Excellence in recognition of his tireless efforts to improve survival rates and quality of life of children with cancer. In recognition of his contributions to Canada, he was awarded the Queen Elizabeth II Golden Jubilee Medal in 2022, and the Diamond Jubilee Medal in 2012.

Dr. Louise Guolla (she/they) finished their training in Pediatric Hematology-Oncology at McMaster University in June 2023. Their previous medical training includes an MD from the University of Toronto and a Pediatric Residency at Memorial University of Newfoundland. She is completing a PhD in Health Research Methodology at McMaster, associated with the Clinician Investigator Program and supported by a CIHR Vanier Canada Graduate Scholarship. Dr. Guolla's research interests and clinical expertise are focused in Leukemia/Lymphoma and Survivorship care, and they are passionate about improving outcomes for Adolescents and Young Adults with cancer. Dr. Guolla holds leadership positions within the International Society of Pediatric Oncology (SIOP), including serving on the Young SIOP Network Steering Group and as the current Chair of the Young SIOP committee in North America, and is a Resident Representative on the Clinician Investigator Program Advisory Committee at the Royal College of Physicians and Surgeons of Canada.

MD, MSc, FRCPC
Professor, Department of Pediatrics, University of Toronto
Staff Oncologist, Solid Tumour Program, The Hospital for Sick Children
Staff Oncologist, Sarcoma Program, and Medical Director, Adolescent and Young Adult Program, Princess Margaret Cancer Centre       

Dr. Abha Gupta received her MD at the University of Toronto. She completed her pediatrics residency at Yale New Haven Children’s Hospital (New Haven, CT) and CHEO (Ottawa) before moving back to Toronto to complete her fellowship in pediatric hematology/oncology at The Hospital for Sick Children. To complement her training, Dr. Gupta completed a one-year fellowship in adolescent and young adult oncology with a focus on sarcoma. She is currently cross appointed as a staff oncologist at both The Hospital for Sick Children and Princess Margaret Cancer Centre.

Dr. Gupta’s primary clinical and research interests include sarcoma, adolescent and young adult oncology, and desmoid tumours. She is the Medical Director of the Adolescent and Young Adult Oncology Program at Princess Margaret, where she is working with a team to create the infrastructure to ensure consistent and high-quality delivery of information and services to young people with cancer. 

Dr. Gupta is also the founding medical director of CanSaRCC, the Canadian Sarcoma Research and Clinical Collaboration, and is interested in clinical trials for sarcoma and desmoid.

MD, PhD, FRCPC
PhD Head, Section of Leukemia and Lymphoma Garron Family Chair in Childhood Cancer Research Division of Haematology/Oncology, The Hospital for Sick Children
Associate Professor, University of Toronto

Dr. Sumit Gupta is the head of the Section of Leukemia and Lymphoma in the Division of Haematology/Oncology at The Hospital Sick Children. He holds the Garron Family Chair in Childhood Cancer Research. He is a member of the Children's Oncology Group (COG) Acute Lymphoblastic Leukemia Committee and is the co-chair of the COG clinical trial for children with SR-ALL.

Nurse Practitioner RN(ec), BScN, MN
McMaster Children’s Hospital         

Eleanor Hendershot is a pediatric nurse practitioner who works in the pediatric oncology outpatient clinic at McMaster Children’s Hospital in both active oncology and cancer survivorship.

Eleanor completed her Master of Nursing in the Acute Care Nurse Practitioner Program at the University of Toronto in 2003. She is cross-appointed to the Lawrence S. Bloomberg Faculty of Nursing, University of Toronto as an adjunct lecturer.

For the last 10 years, Eleanor has had a keen interest in caring for survivors of childhood cancer, both children and adults. She was the Survivorship Disease Committee Nurse at the Children's Oncology Group for four years and is the nursing representative of the protocol committee for the Late Effects after High Risk Neuroblastoma study.

PhD, CPsych
Director, Margaret and Wallace McCain Centre for Child, Youth and Family Mental Health Executive Director, Youth Wellness Hubs Ontario (YWHO)
Professor of Psychiatry, University of Toronto Senior Scientist, Centre for Addiction and Mental Health (CAMH)

Dr. Jo Henderson (they/them) is Director of the Margaret and Wallace McCain Centre for Child, Youth & Family Mental Health at the Centre for Addiction and Mental Health (CAMH) and Executive Director of Youth Wellness Hubs Ontario. They are also a Senior Scientist at CAMH and Professor in the Department of Psychiatry at the University of Toronto. Their work aims to improve access to high quality, integrated services for youth with substance use and/or mental health concerns and their families.

MD, PhD
Developmental Pediatrician & Physician Lead, ABILITY Program
The Hospital for Sick Children

Dr. Joelene Huber is a developmental pediatrician and the Physician Lead of the ABILITY Program at The Hospital for Sick Children. The ABILITY program aims to improve healthcare delivery for children and youth with autism spectrum disorder and/or intellectual/developmental disability who require care at SickKids. Joelene completed medical school at McMaster University, her pediatric residency training at The Hospital for Sick Children and her fellowship in developmental pediatrics at Holland Bloorview. She holds a Master of Science from McGill University and a PhD in Medical Science and Neuroscience from University of Toronto, completed through the Brain and Behaviour Program at SickKids. She has worked for 12 years as a developmental pediatrician with a special interest in autism spectrum disorder (ASD) and has worked with children and youth with ASD in various capacities for over 25 years.

Scientist, RN, PhD
The Hospital for Sick Children

Dr. Lindsay Jibb is a Scientist with Child Health Evaluative Sciences at the SickKids Research Institute, an Assistant Professor at the University of Toronto’s Lawrence S. Bloomberg Faculty of Nursing and a certified pediatric hematology/oncology nurse. Dr. Jibb currently holds the Signy Hildur Eaton Chair in Pediatric Nursing Research at SickKids and the University of Toronto. Her research is focused on pursuing better ways to understand and optimize the psychosocial health of those affected by childhood cancer—particularly through family research partnership

MD, MScHQ, FRCPC
Division of Solid Tumor, St. Jude Children’s Research Hospital

Dr. Kacar is currently a clinical fellow in the Division of Solid Tumor at St. Jude Children's Research Hospital. She completed her MD degree at the University of Belgrade in Serbia and obtained both her pediatric and pediatric hematology/oncology training at McMaster University. She recently obtained her Master of Science in Healthcare Quality (MScQH) from Queen's University. Her interests are pediatric solid tumours, in particular sarcomas, use of novel therapeutics and quality improvement.

Felicia Leung is a Senior Analyst (Epidemiology), Health Analytics at the Pediatric Oncology Group of Ontario (POGO), Toronto. She received her PhD in Epidemiology from the University of Toronto. Dr. Leung's work at POGO includes developing and analysing quality indicators for Ontario's pediatric cancer care system, as well as providing appropriate data and measures to support other quality improvement initiatives. She has a particular interest in utilizing administrative and clinical databases to answer important population, health system and clinical questions.

Vice President and Co-Founder
Fight Like Mason Foundation

Iain is a Honours graduate with a Bachelor of Forensic Science from the University of Windsor. Since 2010 he has held his senior role as a certified Pathologists' Assistant at Windsor Regional Hospital. He has recently stepped back from that role to focus entirely on Fight Like Mason Foundation and assisting children and families with childhood cancer.

Chantelle Bacon & Iain Macri are chief operators and co-founders of Fight Like Mason Foundation. The grassroots organization was formed in 2016 after their son Mason passed away at 4 years old from Rhabdomyosarcoma.

Before passing, Chantelle & Iain made Mason a promise... a promise that they would continue his fight for all the other children diagnosed with childhood cancer. From their experiences, Chantelle and Iain have aimed to fill the gaps in pediatric oncology, helping children and families at every step of their medical journey --- from diagnosis, into remission, survivorship and even bereavement.

With over 10 unique programs, including: research grants, custom medical equipment and comfort and empowering support programs, the organization has raised 1.6 million for their cause in 6 years as a charity.

Chantelle & Iain have been able to continue Mason's fight and legacy by committing to their Mission ; Improving the treatment, care and quality of life of patients diagnosed with childhood cancer.

Fight Like Mason Foundation is here to "Defeat the villain for good!"

MD, FRCPC, FRSC
CIBC Children's Foundation Chair in Child Health Research
Staff Oncologist/Senior Scientist, The Hospital for Sick Children
Professor, Departments of Pediatrics and Medical Biophysics, University of Toronto

Dr. David Malkin is Professor of Pediatrics and Medical Biophysics in the Faculty of Medicine, University of Toronto. He holds the CIBC Children’s Foundation Chair in Child Health Research, is a staff oncologist in the Division of Hematology/Oncology, Director of the Cancer Genetics Program, and a Senior Scientist in the Genetics and Genome Biology Program at The Hospital for Sick Children in Toronto. Dr. Malkin co-leads the SickKids Precision Child Health initiative. He co-directs the SickKids Cancer Sequencing (KiCS) program which integrates next generation sequencing (NGS) into clinical care of children with cancer, and is Director of the pan-Canadian PRecision Oncology For Young peopLE (PROFYLE) initiative which is establishing a pipeline to incorporate NGS into novel clinical trials for children and young adults with hard-to-cure cancers across Canada. Dr. Malkin’s research focuses on genetic mechanisms of childhood cancer susceptibility particularly in the context of TP53 and Li-Fraumeni syndrome. Recently, his work has addressed the application of genomics to clinical surveillance and treatment approaches for children and adults at genetic “high risk” for cancer.

MN NP Paediatric 
The Hospital for Sick Children  

Tara McKeown completed a Bachelor of Science in Kinesiology at the University of Western Ontario and then went on to complete a Bachelor of Science in Nursing at the University of Toronto. She worked at The Hospital for Sick Children Haematology/Oncology inpatient ward as a registered nurse for five years and during that time completed a Master of Nursing with Nurse Practitioner in the pediatric stream. She has worked as a nurse practitioner with the neuro-oncology team at The Hospital for Sick Children since Jan 2013 and is an Adjunct Lecturer for the Lawrence S. Bloomberg Faculty of Nursing at the University of Toronto. Tara is appointed to the Children’s Oncology Group (COG) as a member of the CNS Core Nursing Group and has recently completed work with the evidence-based nursing group with COG. Their manuscript, "Evidence-Based Recommendations for Education Provided to Patients and Families Regarding the Adverse Events of ALK and MEK Inhibitors: A Systematic Review from the Children’s Oncology Group," has been accepted for publication with the Journal of Pediatric Hematology/Oncology Nursing. 

MD
Mount Sinai Hospital

Dr. Jennia Michaeli is a Clinician-Investigator and Assistant Professor at the University of Toronto, ObGyn, and REI at Mount Sinai Fertility Centre. She received her medical degree from the Hebrew University of Jerusalem and completed her residency in obstetrics and gynecology at Shaare Zedek Medical Center in Jerusalem, followed by a clinical fellowship in reproductive endocrinology and infertility at the University of Toronto.

Dr. Michaeli advocates and actively promotes projects to improve care for patients requiring fertility preservation for urgent indications. In addition to her clinical activities, she conducts clinical and basic science research, published in peer-reviewed journals, and presented her work in oral and poster sessions at various international conferences. She takes a particular interest in fertility preservation and reproductive aging, focusing on novel biomarkers of reproductive fitness and oocyte and sperm quality.

PhD, RN, PCNS-BC
Assistant Professor, School of Nursing
University of Wisconsin-Madison

Dr. Kitty Montgomery is an Assistant Professor of Nursing at the University of Wisconsin-Madison. Dr. Montgomery has over a decade of clinical experience practicing in pediatric hematology, oncology and cellular therapy settings where she was responsible for nursing and patient/family education, quality improvement and evidence-based practice. Her research interests include understanding the symptom experiences of children with advanced cancer using patient-reported outcomes, antecedents and consequences of poorly controlled symptoms, and symptom communication among child-caregiver dyads.

MB, BChir, PhD
Staff Oncologist, The Hospital for Sick Children
Associate Professor, University of Toronto

Daniel Morgenstern is a staff oncologist at The Hospital for Sick Children, Toronto, and Associate Professor at the University of Toronto. He originally trained and worked in the UK, primarily at Great Ormond Street Hospital in London where he was clinical lead for the neuroblastoma and autograft programs, and an active member of SIOPEN. Dr. Morgenstern moved to SickKids, Toronto, in 2016 as Director of the New Agent and Innovative Therapy (NAIT) and Therapeutic mIBG programs, and co-lead of the neuroblastoma service. He is also Medical Director of the Oncology/BMT Clinical Trials Support Unit. Dr. Morgenstern’s clinical activities are focused on neuroblastoma and solid tumour patients participating in early phase clinical trials. His research interests are in early phase trials and, in particular, the use of immune checkpoint inhibitors in pediatric cancers and the development of precision medicine approaches for pediatric solid tumours.

Alia Petropoulos is an Interprofessional Education Specialist in the Hematology/Oncology/Blood and Marrow Transplant & Cellular Therpay program at the Hospital for Sick Children. Since 2012, Alia has practiced as a registered nurse in various roles including Clinical Support Nurse in Charge and Clinical Nurse Specialist, focusing on building patient and cargiver education, and advancing nursing practice through education. In her current role, Alia develops and supports frontline nursing orientation and ongoing education for the H/O/BMT & CT program. Additionally, Alia is a Certified Pediatric Hematology Oncology nurse and instructor for the APHON Pediatric Onology Chemotherapy/Biotherapy Provider Course.

BMBCh, PhD
Professor of Pediatric Oncology
Director, Candlelighters Supportive Care Centre,
University of York/Hull-York Medical School

Dr. Bob Phillips is a Senior academic at CRD and HYMS and an Honorary Consultant in Pediatric/ Teenage-Young Adult Oncology at Leeds Children's Hospital. His main areas of work are in the development of individual participant data (IPD) meta-analysis, supportive care management, and the development of skills in appraisal and translation of clinical research in practice. He is the lead of the PICNICC collaboration, “Predicting Infectious Complications in Children with Cancer,” which was formed by engaging international clinical and methodological experts, parent representatives and healthcare researchers to investigate primarily the patterns of risk in febrile neutropenia. The PICNICC collaboration consists of 22 different study groups from 15 countries and is actively engaged in involving new members from around the world to further develop its aims.

Ashwini Pugazhendhi is currently in her final year of the Bachelor of Health Sciences (Honors) program at McMaster University. She is passionate about enhancing grief literacy within communities and advocating for improved mental health support for pediatric populations.

MD, FRCPC
The Hospital for Sick Children

Dr. Angela Punnett is a staff oncologist with the leukemia/lymphoma section in the Division of Haematology/Oncology at SickKids and an Associate Professor at the University of Toronto. She is a member of the Hodgkin Lymphoma Steering Committee of the Children's Oncology Group.

PhD, RN, CNS, CPHON
Nurse Scientist Advanced Practice Registered Nurse (APRN)
Department of Nursing Research and Evidence-Based Practice, Center for Professional Excellence and Inquiry
Clinical Assistant Professor, Division of Hematology/Oncology, Department of Pediatrics Stanford University

Dr. Kim Pyke-Grimm is a Nurse Scientist in the Department of Nursing Research and Evidence-Based Practice at Stanford Medicine Children’s Health. She has over 35 years of experience as a bedside nurse, head nurse and clinical nurse specialist in pediatric hematology/oncology/stem cell transplant. She received a Bachelor of Nursing degree from Dalhousie University, Master of Nursing degree from UCLA, PhD from UCSF School of Nursing and completed a postdoctoral fellowship in palliative care at Stanford University. She has a certificate in pediatric bioethics from the Children's Mercy Bioethics Center. She is appointed as a Clinical Assistant Professor at Stanford School of Medicine, Department of Pediatrics, Division of Hematology/Oncology/Stem Cell Transplantation. Her research interests include treatment decision making in children, adolescents and young adults with cancer, and their families, palliative care and clinical ethics. She holds leadership positions in the Children’s Oncology Group and International Family Nursing Association. She is on the editorial boards of several journals and has received research funding from multiple sources.

PhD 
Associate Professor, Division of Psychosocial Oncology, University of Calgary 

Dr. Fiona Schulte is an Associate Professor in the Department of Oncology, Division of Psychosocial Oncology in the Cumming School of Medicine at the University of Calgary. She is also a registered psychologist in the Hematology, Oncology and Transplant Program at the Alberta Children’s Hospital. Fiona’s research is broadly interested in enhancing the patient and family experience for children, adolescents and young adults diagnosed with cancer. She is passionate about advocating for the needs of survivors and ideally working to improve the quality of life of this population. Fiona is Past President of the Canadian Association of Psychosocial Oncology. She is also a member of a number of national and international committees focused on improving the care of pediatric and adolescent cancer patients, survivors and their families including the Canadian Pediatric Cancer Consortium (CPCC), Children’s Oncology Group Long-Term Follow-Up Guidelines psychosocial task force and the International Guidelines Harmonization Group psychosocial task force. She has been recognized for her research with the Canadian Association of Psychosocial Oncology Research Excellence Award (2022), an International Society of Pediatric Oncology Young Investigator Award, the International Psycho-Oncology Society Hiroomi Kawano New Investigator Award (2018) and Calgary’s Avenue Magazine Top 40 Under 40 (2017). 

MD, FRCPC
Childrens's Hospital, London Health Sciences Centre

Dr. Jennifer Seelisch is a Pediatric Hematologist/Oncologist at the Children's Hospital at London Health Sciences Centre in London, Ontario and an Assistant Professor at Western University. She completed medical school at Western University, pediatric residency at the Universiy of Ottwaw/Children's Hospital of Eastern Ontario, and fellowship at the Hospital for Sick Children in Toronto.

Dr. Seelisch's main areas of oncology interest are in Hodgkin lymphoma, acute lymphoblastic leukemia and supportive care. She is the Co-Chair of the international Staging Evaluation and Response Criteria Harmonization (SEARCH) for Childhood, Adolescent and Young Adult Hodgkin Lymphoma (CAYAHL) Group and is a member of the Children's Oncology Group Hodgkin Lymphoma Committee. Dr. Seelisch is the vice-chair of the COG trial ALTE21C1 (assessing clonal hematopoiesis and cardiovascular disease in HL survivors). She sits on the COG Supportive Care Clinical Practice Guidelins Task Force, and the POGO Supportive Care Steering Committee. She enjoys medical education and is the Director of Pediatric Undergraduate Medical Education at Western University Schulich School of Medicine and Dentistry.

Roaa Shoukry is a research assistant at the Child Health Evaluative Sciences at the Hospital for Sick Children, and her work is shaped by her service experience in children and youth health. Her research projects, on evaluating interventions in pediatric oncology, are an extension of her interest in assessing the quality and cost of care. She hopes to conduct research that is rooted in active partnerships.

Roaa holds an honour bachelor's degree in neuroscience and physiology from the University of Toronto and is currently pursuing a master’s degree in health economics at the Institute of Health Policy, Management and Evaluation. In her free time, she is typically tending to her plants.

PhD, FCCMG 
Senior Scientist, Garron Family Chair in Childhood Cancer Research  
Department of Pediatric Laboratory Medicine and Genetics and Genome Biology, The Hospital for Sick Children

Dr. Adam Shlien is a Senior Scientist in the Genetics & Genome Biology Program at SickKids and a Director in the Genome Diagnostics Division of the Department of Pediatric Lab Medicine. He received his PhD from the University of Toronto for the study of genomic copy number variation and cancer. He continued his training as a postdoctoral fellow at the Wellcome Trust Sanger Institute where he developed methods to understand the transcriptional consequences of point mutation in cancer. 
 
With over 20 years of experience in bioinformatics and genomics, of which 10 years have been as a PI at SickKids, Dr. Shlien co-leads the Kids Cancer Sequencing Program (KiCS), which he helped establish in 2016. Dr. Shlien’s research involves understanding the mutational processes that lead to childhood cancer, for which he has received a number of awards, including the St Baldrick’s Robert J. Arceci  Innovation Award, an unrestricted prize for “out of the box” research in pediatric cancer. 
.

RN
ABILITY Program
The Hospital for Sick Children

Chantal St. Jules is a registered nurse with over 20 years of experience working in the pediatric medicine department at The Hospital for Sick Children, Toronto. She has experience as an inpatient nurse, clinical support nurse, clinical orientation support nurse and team lead. Her outpatient experiences have included project lead in the development of ACE Space, a medical day unit within the pediatric medicine department, clinical nurse coordinator and clinic nurse in the Pediatric Consultation Clinic and the ABILITY Program, supporting children with autism and intellectual disabilities.

Chantal is an expert in hospital navigation and coming up with out-of-the-box innovative solutions supporting individualized care needs. She was the 2023 recipient of the Grace Evelyn Simpson Reeves – Nursing Innovation Award. Chantal was an integral member in the creation of the Adaptive Care Planning Program and has successfully supported 100+ children/youth with intellectual and developmental disabilities and/or autism spectrum disorder to receive the right care, at the right time, at the right place.

APRN, MS, CPNP-AC/PC, CPON
Nurse Practitioner
Division of Hematology/Oncology/BMT, Nationwide Children’s Hospital

Stacy Whiteside APRN, MS, CPNP-AC/PC, CPON received both her undergraduate and graduate degrees in nursing from Ohio State University. She has spent her entire nursing career in the Hematology/Oncology/BMT Department at Nationwide Children's Hospital. Stacy has been a passionate advocate for adolescents and young adults (AYAs) with cancer for many years. On the national level, she serves as the nursing representative to the Children's Oncology Group AYA Committee and is the chair of the patient navigation committee of the Oncofertility Consortium. Her clinical focus is the care of patients with soft tissue and bone malignancies, and she is a member of the Sarcoma team at Nationwide Children’s Hospital. As a founding member of the Fertility and Reproductive Health Program, Stacy continues to serve on the fertility team providing counselling and fertility preservation options for all patients with medical conditions or treatments that may impact their future fertility and reproductive health.

MD, MBI, FRCPC, FAAP
Pediatric Oncology Attending, The Hospital for Sick Children
Assistant Professor, The University of Toronto

Dr. Adam Yan is a staff oncologist in the Section of Leukemia/Lymphoma at SickKids and an Assistant Professor in the Faculty of Medicine at the University of Toronto. Dr. Yan completed his residency in pediatric hematology/oncology at SickKids and went on to complete a clinical informatics fellowship at Boston Children's Hospital and a Master of Biomedical Informatics at Harvard Medical School.

Dr. Yan is currently the oncology informatics physician lead at SickKids. Dr. Yan's academic work focuses on improving the use of digital health tools to enhance the care of children with cancer and blood disorders in Canada. 

Ally Yu is in her final year of Master’s studies at the University of Toronto’s Institute of Medical Science. Her research is supervised by Dr. Gary Rodin at the Princess Margaret Cancer Centre’s Department of Supportive Care. Prior to her Master’s, Ally studied neuroscience for her undergraduate degree at McGill University. A leukemia diagnosis after graduation shifted her research interest from the brain to cancer. Her personal experience provided a deeper understanding of the emotional and social challenges faced by young cancer patients and their families and their need for specialized psychosocial support. Her Master’s project is on a pilot trial evaluating a novel psychotherapeutic intervention for family caregivers of children with acute leukemia at SickKids. This intervention is called Emotion and Symptom-focused Engagement (EASE).

MN, NP-Pediatric
The Hospital for Sick Children

Sue has practiced as a Nurse Practitioner in the Leukemia and Lymphoma Section at The Hospital for Sick Children since 2002. Currently, Sue is serving as the Nursing Discipline Chair for the Children's Oncology Group.